BR0308396A - Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus - Google Patents

Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus

Info

Publication number
BR0308396A
BR0308396A BR0308396-9A BR0308396A BR0308396A BR 0308396 A BR0308396 A BR 0308396A BR 0308396 A BR0308396 A BR 0308396A BR 0308396 A BR0308396 A BR 0308396A
Authority
BR
Brazil
Prior art keywords
diabetes mellitus
conditions associated
complications
including conditions
treating
Prior art date
Application number
BR0308396-9A
Other languages
English (en)
Inventor
Haydn P Pritchard
Kishor M Wasan
Tatjana Lukic
Original Assignee
Forbes Medi Techi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forbes Medi Techi Inc filed Critical Forbes Medi Techi Inc
Publication of BR0308396A publication Critical patent/BR0308396A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSO DE TRATAMENTO DE DIABETES MELLITUS INCLUINDO CONDIçõES ASSOCIADAS COM DIABETES MELLITUS E COMPLICAçõES DE DIABETES MELLITUS". Um processo para o tratamento de diabetes mellitus e condições associadas com diabetes mellitus em um animal compreende administração de uma quantidade não-tóxica terapeuticamente efetiva de um ou mais dos seguintes compostos: fórmulas (I, II, III) onde R é uma metade fitosterol ou fitostanol, R2 é derivado de ácido ascórbico e R3 é hidrogênio ou qualquer metal, metal alcalino terroso, ou metal alcalino; e todos seus sais.
BR0308396-9A 2002-03-14 2003-03-14 Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus BR0308396A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9874502A 2002-03-14 2002-03-14
PCT/CA2003/000369 WO2003075931A1 (en) 2002-03-14 2003-03-14 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus

Publications (1)

Publication Number Publication Date
BR0308396A true BR0308396A (pt) 2005-01-11

Family

ID=27804294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308396-9A BR0308396A (pt) 2002-03-14 2003-03-14 Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1482950A1 (pt)
JP (1) JP2005528353A (pt)
KR (1) KR20040104513A (pt)
CN (1) CN1681514A (pt)
AU (1) AU2003218547B2 (pt)
BR (1) BR0308396A (pt)
CA (1) CA2478931A1 (pt)
NO (1) NO20044346L (pt)
NZ (1) NZ535200A (pt)
RU (1) RU2334518C2 (pt)
WO (1) WO2003075931A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
KR101823699B1 (ko) * 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
AU2016314373A1 (en) * 2015-09-03 2018-03-29 Natural Shield Israel 2016 Ltd Combined compositions for controlling blood sugar levels, hepatoprotection, and for prevention and treatment of related medical conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002101483A (ru) * 1999-06-23 2003-09-20 Форбз Меди-Тек Инк. (Ca) Коньюгаты фитостерола или фитостанола с аскорбиновой кислотой и их применение для лечения или профилактики сердечно-сосудистых заболеваний

Also Published As

Publication number Publication date
RU2004130463A (ru) 2005-04-10
WO2003075931A1 (en) 2003-09-18
AU2003218547B2 (en) 2007-11-01
NO20044346L (no) 2004-12-09
KR20040104513A (ko) 2004-12-10
CN1681514A (zh) 2005-10-12
AU2003218547A1 (en) 2003-09-22
RU2334518C2 (ru) 2008-09-27
NZ535200A (en) 2007-07-27
CA2478931A1 (en) 2003-09-18
EP1482950A1 (en) 2004-12-08
JP2005528353A (ja) 2005-09-22

Similar Documents

Publication Publication Date Title
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
MXPA03011981A (es) 3-fluoruro-pirrolidinas como agentes antidiabeticos.
GB0206860D0 (en) Compounds
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
BRPI0408784A (pt) método para usar um composto
ATE398128T1 (de) Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel
NO20051263L (no) Ny anvendelse av benzotiazolderivater
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
DE69125216T2 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
BR0113389A (pt) Compostos que inibem a atividade do fator xa
BR9910115A (pt) Cetolìdeos da classe dos lactamas de 5 elementos
NO944914L (no) Fremgangsmåte for å inhibere autoimmunsykdommer
DK0599890T3 (da) Geneserinderivater som cholinesteraseinhibitorer
BR0308396A (pt) Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
BRPI0409151A (pt) uso de derivados de 10-hidróxi-10,11-diidrocarbamazepina para o tratamento de transtornos afetivos
DE69629195D1 (de) Inhibitor von gehirnödemen
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
BR0313278A (pt) Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo e sua utilização, método para o tratamento e profilaxia de enfermidades e obesidade e utilização dos compostos
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
BR0307521A (pt) Inibidores de adesão da célula mediada por alfa l beta2 integrina

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.